See more : Editas Medicine, Inc. (EDIT) Income Statement Analysis – Financial Results
Complete financial analysis of Devyser Diagnostics AB (publ) (DVYSR.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Devyser Diagnostics AB (publ), a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- SAMHI Hotels Limited (SAMHI.NS) Income Statement Analysis – Financial Results
- D&D Pharmatech (347850.KQ) Income Statement Analysis – Financial Results
- Star Health and Allied Insurance Company Limited (STARHEALTH.BO) Income Statement Analysis – Financial Results
- Grupo Aeroportuario del Sureste, S. A. B. de C. V. (ASR) Income Statement Analysis – Financial Results
- ENGAGE XR Holdings plc (6VR.IR) Income Statement Analysis – Financial Results
Devyser Diagnostics AB (publ) (DVYSR.ST)
About Devyser Diagnostics AB (publ)
Devyser Diagnostics AB (publ) develops, manufactures, and sells diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia. The company offers products in the areas of post-transplantation; thalassemia; breast, colorectal, and ovarian cancer; non-invasive fetal RHD screening prenatal testing, hereditary, cystic fibrosis, cardiovascular, male infertility, and rapid aneuploidy analysis, as well as accessories. Its products are used for targeted cancer treatment to diagnosis genetic diseases and transplant patient follow-up. The company also provides software programs for data processing and analysis, as well as interpretation of test results; and Amplicon Suite and Advyser software programs to screen markers and follow up samples for the same patient. Devyser Diagnostics AB (publ) was incorporated in 2004 and is headquartered in Hägersten, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 169.30M | 126.61M | 93.48M | 65.69M | 64.30M | 48.15M |
| Cost of Revenue | 21.20M | 20.84M | 18.82M | 9.04M | 12.03M | 13.35M |
| Gross Profit | 148.10M | 105.77M | 74.66M | 56.65M | 52.28M | 34.80M |
| Gross Profit Ratio | 87.48% | 83.54% | 79.87% | 86.24% | 81.29% | 72.28% |
| Research & Development | 41.10M | 28.65M | 20.82M | 21.70M | 9.90M | 8.62M |
| General & Administrative | 42.00M | 37.90M | 28.78M | 11.72M | 0.00 | 0.00 |
| Selling & Marketing | 121.50M | 94.20M | 46.88M | 30.18M | 0.00 | 0.00 |
| SG&A | 163.50M | 132.07M | 75.65M | 41.90M | 33.73M | 29.69M |
| Other Expenses | 0.00 | 0.00 | 1.78M | 1.77M | 1.65M | 0.00 |
| Operating Expenses | 204.60M | 160.72M | 96.47M | 63.61M | 43.63M | 38.31M |
| Cost & Expenses | 225.80M | 181.56M | 115.29M | 72.65M | 55.66M | 51.66M |
| Interest Income | 5.00M | 300.00K | 6.00K | 2.00K | 0.00 | 0.00 |
| Interest Expense | 800.00K | 500.00K | 939.00K | 925.00K | 785.00K | 596.00K |
| Depreciation & Amortization | 13.10M | 6.16M | 3.28M | 2.96M | 2.32M | 1.25M |
| EBITDA | -43.80M | -46.02M | -18.05M | -6.96M | 13.26M | 1.61M |
| EBITDA Ratio | -25.87% | -38.53% | -19.82% | -6.08% | 17.06% | -4.70% |
| Operating Income | -56.50M | -54.95M | -21.81M | -6.96M | 8.65M | -3.51M |
| Operating Income Ratio | -33.37% | -43.40% | -23.33% | -10.59% | 13.45% | -7.29% |
| Total Other Income/Expenses | 2.10M | 2.25M | -1.06M | -981.00K | -261.00K | 3.28M |
| Income Before Tax | -54.40M | -52.72M | -22.28M | -10.85M | 10.16M | -232.00K |
| Income Before Tax Ratio | -32.13% | -41.64% | -23.83% | -16.52% | 15.79% | -0.48% |
| Income Tax Expense | -800.00K | -6.80M | -1.18M | -985.00K | 2.62M | -751.00K |
| Net Income | -53.60M | -45.95M | -20.73M | -10.91M | 7.01M | 519.00K |
| Net Income Ratio | -31.66% | -36.29% | -22.17% | -16.61% | 10.90% | 1.08% |
| EPS | -3.31 | -2.89 | -1.85 | -375.94 | 241.52 | 17.88 |
| EPS Diluted | -3.31 | -2.89 | -1.85 | -375.94 | 231.01 | 17.28 |
| Weighted Avg Shares Out | 16.18M | 15.92M | 11.23M | 29.02K | 29.02K | 29.02K |
| Weighted Avg Shares Out (Dil) | 16.18M | 15.92M | 11.23M | 29.02K | 30.34K | 30.03K |
Source: https://incomestatements.info
Category: Stock Reports